免疫球蛋白重链可变段和T细胞受体可变段的分子进化研究

为阐明免疫球蛋白(Ig)和T细胞受体(TCR)在抗体多样性产生机理上的异同,作者比较了Ig重链可变段(Ig V_H)和TCR可变段(TCR V)的密码子替代率和协同进化,并分析异同的原因。共搜集8种鼠和3种人的TCR α链可变段(V_α),11种鼠和1种人的TCRβ链可变段(V_β),以及2种鼠和4种人的T细胞γ链可变段;同时搜集11种鼠、3种人、3种南美鳄鱼和1种鲨鱼的Ig V_(H_(o))研究结果揭示:(1)对编码蛋白质的密码子来说,TCR V(包括V_α和V_β)的核苷酸替代率为Ig V_H的2.4倍,说明前者有更高的替代率。(2)以协同进化而言,TCR V和Ig V_H的基因重复率分别为1.7×10~(-6)和1.6×10~(-6)/基因年。两者几乎相同,均系低速保持者。TCR V的数目(V_α为100,V_β为30)远少于Ig V_H(数目为300),原因是前者受到主要组织相容性复合体的制约,即受到负选择,这与中性学说观点相一致。文章还讨论了体细胞突变和DNA重排对两类抗体多样性产生上的作用,并探讨了IgV_H和TCR V的假基因问题。     

α—受体阻断剂对大鼠心肌梗塞心律失常与梗塞范围的保护作用

在大鼠心肌梗塞模型上,观察了α-受体阻断剂的抗心律失常作用。在对照组22只鼠中,由于心梗所致室早、室速 和室颤的出现率分别为77.3%、77.3%、59.1%,并有27.2%死亡,而用哌唑嗪鼾的大鼠（n=12),只有41.6%出现早搏,未出现室速、室颤和死亡,酚妥拉明（n=12)和用利用血平耗竭儿茶酚胺（n=5)后,有类似结果,心得安（n=14)组与对照组无明显差别,哌唑嗪、酚妥拉明和心得安分别使心肌梗塞范围自475%减少到26.5%(P<0.01)、36.5%(P>0.05)和33.9%(P<0.05),利血平耗竭儿茶酚胺后,梗塞范围最小,为18.6%(P<0.01),心梗所致的心律失常,主要与α-受体有关,而α- 受体阻断剂与β-受体阻断剂均可减小梗塞范围。     

人肝癌细胞表皮生长因子受体以及佛波酯对它的调度

Using radioligand binding assay, the presence of epidermal growth factor (EGF) receptors in cells of two human liver cancer cell lines, BEL-7402 and SMMC-7721, was demonstrated. The ligand binding data were analyzed by a computer program. The dissociation constants (KD) of the ligand-receptor binding complex at equilibrium for 7402 and 7721 cells were 1.2 nM and 0.8 nM respectively, and their number of EGF receptors per cell were 6.2 x 10(4) and 2.5 x 10(4) respectively. After the treatment of cells with phorbol 12-myristate 13-acetate (PMA), no change either in the affinity or in the number of EGF receptors was found in 7721 cells. However, in the case of 7402 cells, while the number of receptors, like 7721 cells, remained unchanged, the affinity of EGF receptors displayed a time dependent modulation after PMA treatment. It dropped within the first hour to a KD value of 3.0 nM and then gradually returned to the normal control value at 48 hours or even slightly higher than normal (0.95 nM) at 96 hours of treatment. The modulation or down-regulation of EGF receptors by PMA in 7402 cells was paralleled by the simultaneous inhibition of DNA synthesis in these cells as evidenced from their reduction of 3H-TdR uptake. It is not clear what is the basis for the differences found between 7402 cells and 7721 cells in their number of EGF receptors per cell and their responsiveness to PMA treatment. It might be related to their difference in autocrine secretion of alpha-transforming growth factors.(ABSTRACT TRUNCATED AT 250 WORDS)     

兔小脑延髓池注射纳洛酮对刺激肾神经传入纤维血压效应的影响

本文目的在于用小脑延髓池注射(Ict)受体阻断剂的方法,观察低位脑干阿片样受体与α肾上腺素受体对刺激肾神经传入纤维和主动脉神经降压效应的影响。实验在戊巴比妥钠麻醉兔中进行。Ict人工脑脊液(CSF)对刺激肾神经传入纤维和主动脉神经的降压反应均无明显影响。Ict 550nmol纳洛酮可显著抑制刺激肾神经传入纤维的降压效应,但能明显增强刺激主动脉神经的降压效应。Ict酚妥拉明可显著抑制刺激肾神经传入纤维和主动脉神经的降压效应。Ict纳洛酮可逆转酚妥拉明对刺激主动脉神经的降压效应的抑制,但不影响酚妥拉明对刺激肾神经传入纤维的降压效应的抑制。Ict纳洛酮和酚妥拉明都不影响刺激肾神经传入纤维降压反应与主动脉压力感受性反射的抑制性相互作用。Ict酚妥拉明使MAP显著下降;纳洛酮不影响MAP,但可逆转酚妥拉明降低MAP的作用。上述结果提示,激动低位脑干的阿片样受体可增强刺激肾神经传入纤维的降压作用,减弱刺激主动脉神经的降压作用,激动α肾上腺素受体可增强刺激肾神经传入纤维和主动脉神经的降压反应     

氨甲酰胆碱和Impromidine对CFU—S细胞周期的影响

正常情况下处于S期的CFU-S比例低于10％。氨甲酰胆碱(Cach 10~(-13)—10~(-9)mol/L)和Impromidine(Impro 10~(-9)—10~(-4)mol/L)在体外与小鼠骨髓细胞短时培育后,增加了CFU-S对细胞毒剂羟基脲的敏感性。反应最大时,9d和13dCFU-S的减少率分别是32.8和60.6％(Cach)以及38.4和49.5％(Impro)。这种效应可分别被胆碱能N受体阻断剂筒箭毒(10~(-6)mol/L)和组胺H_2受体阻断剂甲氰咪呱(10~(-6)mol/L)所阻断,表明9d和13d CFU-S表面胆碱能N受体和组胺H_2受体的密度或活性存在差别,再次证实了CFU-S是一个不均一的细胞群。